Artificial Intelligence in medicine: an introduction to the AI Act approach to regulating the matter
DOI:
https://doi.org/10.82015/NNR.2025.100109Keywords:
AI Act; GPAI; Risk Based Approach; General purpose ai codes of conduct; High risk ai systems.Abstract
The document addresses issues related to general artificial intelligence, with a specific focus on regulatory, ethical, and technological implications. It analyzes the main risks associated with the adoption of generative AI models, including aspects of security, transparency, and data protection. Particular attention is paid to the European regulatory framework, with reference to the AI Act and the General-purpose AI Code of Practice. The text also proposes guidelines for responsible AI governance, suggesting interdisciplinary approaches that balance innovation and the protection of fundamental rights. Finally, it discusses future scenarios and strategies for mitigating the systemic risks associated with rapid developments in AI technology.
References
1. Commissione Europea (2025). Codice di condotta per i modelli di IA per finalità generali, https://digital-strategy.ec.europa.eu/en/policies/contents-code-gpai.
2. Conti, F., Banchelli, M., Bessi, V., Cecchi, C., Chiti, F., Colantonio, S., D’Andrea, C., de Angelis, M., Moroni, D., Nacmias, B., Pascali, M. A., Sorbi, S., Matteini, P. (2024). Harnessing topological machine learning in Raman spectroscopy: Perspectives for Alzheimer’s disease detection via cerebrospinal fluid analysis. Journal of the Franklin Institute, 361(18), 107249. https://doi.org/10.1016/j.jfranklin.2024.107249.
3. De Ferrari, G. M., Aldinucci, M., et al. (2021). Machine learning for predicting outcomes in patients with acute myocardial infarction. The Lancet, 397, 199.
4. Ebers, M. (2025). Truly risk-based regulation of artificial intelligence: How to implement the EU’s AI Act. European Journal of Risk Regulation, 16(2), 684–703. https://doi.org/10.1017/err.2024.78
5. Gellert, R. (2021). The role of the risk-based approach in the General Data Protection Regulation and in the European Commission’s proposed Artificial Intelligence Act: Business as usual? Journal of Ethics and Legal Technologies, 3(2), 15–33. https://doi.org/10.14658/pupj-jelt-2021-2-2.
6. Gstrein, O. J., Haleem, N., and Zwitter, A. (2024). General-purpose AI regulation and the European Union AI Act. Internet Policy Review, 13(3). https://doi.org/10.14763/2024.3.1790
7. Hacker, P., Kasirzadeh, A., and Edwards, L. (2025). AI, digital platforms and the new systemic risk. arXiv preprint. https://arxiv.org/abs/2509.17878.
8. Hao, J. , Kwapong, W. R., Shen, T., Fu, H., Xu, Y., Lu, Q., Liu, S., Zhang, J., Liu, Y., Zhao, Y., Zheng,
Y., Frangi, A. F., Zhang, S., Qi, H., and Zhao Y. (2024). Early detection of dementia through retinal imaging and trustworthy AI. npj Digital Medicine, 7, 281.
https://doi.org/10.1038/s41746-024-01292-5
9. HSR Research (2020). AI-SCORE, a project to calculate prognostic risk from Covid-19. IRCCS Ospedale San Raffaele: scientific research. https://shorturl.at/ai0gt.
10. IEO-Monzino. Converting unstructured clinical data into structured data for scientific research with Google Cloud - https://cloud.google.com/customers/ieo-monzino.
11. Istituto Mario Negri. (2022). I3LUNG: Un progetto Horizon Europe per l’implementazione di cure mediche personalizzate basate sull’intelligenza artificiale (AI) nei pazienti con tumore al
polmone.
12. Kulothungan, V. (2025). Securing the AI frontier: Urgent ethical and regulatory imperatives for AI-driven cybersecurity. arXiv preprint. https://doi.org/10.1109/BigData62323.2024.10826010.
13. Kusche, I. (2024). Possible harms of artificial intelligence and the EU AI Act: Fundamental rights and risk. Journal of Risk Research, 1–14.
https://doi.org/10.1080/13669877.2024.2350720.
14. Kwon, S. Y., and Moon, J. S. (2025). Advances in continuous glucose monitoring: Clinical applications. Medicina, 60(12), 1951. https://doi.org/10.3803/EnM.2025.2370.
15. Ledro, C., Nosella, A., and Vinelli, A. (2022). Artificial intelligence in customer relationship management: Literature review and future research directions. Journal of Business and Industrial Marketing, 37(13), 48–66. https://doi.org/10.1108/JBIM-07-2021-0332
16. Lucchi, N. (2024). ChatGPT: A case study on copyright challenges for generative artificial intelligence systems. European Journal of Risk Regulation, 15(Special Issue 3), 602–624. https://doi.org/10.1017/err.2023.59.
17. Maiorino, M. I., Signoriello, S., Maio, A., Chiodini, P., Bellastella, G., Scappaticcio, L., Longo, M., Giugliano, D. and Esposito, K. (2020). Effects of continous glucose monitoring on metrics of glycemic control in diabetes: A systematic review with meta-analysis of randomized
controlled trials. Diabetes Care, 43(5), 1146–1156. DOI: 10.2337/dc19-1459.
18. Marr, B. (2023). A short history of CHATGPT: How we got to where we are today. Forbes. https://shorturl.at/UdoqU.
19. Palmisano, A., Vignale, D., Boccia, E., Nois, A., Gnasso, C., Leone, R., Montagna, M., Nicoletti, V., Bianchi, A. G., Brusamolino, S., Dorizza, A., Moraschini, M., Veettil, R., Cereda, A., Toselli, M., Giannini, F., Loffi, M., Patelli, G., Monello, A., Iannopollo, G., Ippolito, D., Mancini, E. M., Pontone, G., Vignali, L., Scarnecchia, E., Iannacone, M., Baffoni, L., Sperandio, M., de Carlini, C.
C., Sironi, S., Rapezzi, C., Antiga, L., Jagher, V., Di Serio, C., Furlanello, C., Tacchetti, C., Esposito, A., (2022). AI-SCoRE (Artificial Intelligence – SARS-CoV-2 Risk Evaluation): a fast, objective and fully automated platform to predict the outcome in COVID-19 patients. Cardiac radiology, (127):960-972. https://doi.org/10.1007/s11547-022-01518-0.
20. Pesheva, E. (2024). Does AI Help or Hurt Human Radiologists’ Performance? It Depends on the Doctor. Harvard Medical School. https://shorturl.at/yc1V5.
21. Presno Linera, M. Á., and Meuwese, A. (2025). Regulating AI from Europe: A joint analysis of the AI Act and the Framework Convention on AI. The Theory and Practice of Legislation, 1–20. https://doi.org/10.1080/20508840.2025.2492524.
22. Rangone, N., and Megale, L. (2025). Risks without rights? The EU AI Act’s approach to AI in law and rule-making. European Journal of Risk Regulation, 1–16.
https://doi.org/10.1017/err.2025.13
23. Romano, L. and Università Federico II. (2023). L’intelligenza artificiale può interpretare le immagini TAC del pancreas, vedendo un tumore duttale che il radiologo può non riuscire a diagnosticare perché troppo piccolo. Ospedale Cardarelli Napoli - Dipartimento di Ingegneria Elettrica e delle Tecnologie dell’Informazione Università Federico II.
24. Scalzini, S. (2025). Scientific authorship e intelligenza artificiale: Questioni e prospettive. FSE – Online First (10). https://shorturl.at/KtNVp.
25. Triguero, I., Molina, D., Poyatos, J., Del Ser, J., and Herrera, F. (2023). General purpose artificial intelligence systems (GPAIS): Properties, definition, taxonomy, open challenges and implications. arXiv preprint. https://arxiv.org/abs/2307.14283.
26. Uuk, R., Gutierrez, C. I., Guppy, D., Lauwaert, L., Kasirzadeh, A., Velasco, L., Slattery, P., and Prunkl, K. (2024). A taxonomy of systemic risks from general-purpose AI. arXiv preprint. https://doi.org/10.2139/ssrn.5030173.
27. Yang, S. A., and Zhang, A. H. (2024). Generative AI and copyright: A dynamic perspective. arXiv preprint. https://doi.org/10.2139/ssrn.4716233.
28. Zahedani, A.D., McLaughlin, T., Veluvali, A., Aghaeepour, N., Hosseinian, A., Agarwal, S., Ruan, J., Tripathi, S., Woodward, M., Hashemi, N., and Snyder, M. (2023). Digital health application integrating wearable data and behavioral patterns improves metabolic health. npj Digital Medicine, 6, 216. https://doi.org/10.1038/s41746-023-00956-y.
